Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RELATLIMAB vs REPAGLINIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RELATLIMAB vs REPAGLINIDE: Safety Overview

Metric RELATLIMAB REPAGLINIDE
Total FAERS Reports 177 2,544
Deaths Reported 29 169
Death Rate 16.4% 6.6%
Hospitalizations 145 1,517
Average Patient Age 64.5 yrs 71.9 yrs
% Female Patients 34.6% 45.5%
FDA Approval Date N/A Apr 24, 2015
Manufacturer N/A Rising Pharma Holdings, Inc.
Route N/A ORAL
Marketing Status N/A Discontinued